615.665.7100
Our Vision
Health care is vital to our society. With costs continuing to rise, health care currently accounts for approximately 17% of our country's gross domestic product. While this level of investment in health care allows the U.S. to lead the world in medical innovation, the continually rising costs make it increasingly clear that reform of our health care system is important.
Although reform will be a long term process and the outcomes are not clear, we can expect to see more universal insurance coverage that we anticipate will lead to a greater demand for services. Along with broader insurance coverage, we should expect downward pressure on reimbursement to providers of health care as government and business struggle to meet their commitments to consumers of healthcare.
It is also likely that we will see a greater focus on chronic disease given that our country spends a disproportionate share of our health care resources on these diseases. Innovation in health care delivery is vital as government, business and individuals seek to spend their health care funds wisely.
We believe our concept is an innovation that enables purchasers of health care to spend wisely, but still receive quality care. We focus on managing total health care costs associated with chronic airway diseases rather than isolated, episodic spending. We believe our centers can document better outcomes in terms of both cost and quality as we bring together all the resources necessary to get our arms around these diseases and avoid unnecessary emergency room visits, hospitalizations and physician visits.
We utilize evidence based medical protocols to make sure we provide neither too much nor too little services. Our multi-disciplinary, fully resourced care delivery platform allows for a timely and definitive diagnosis, a clinically appropriate and cost effective treatment plan and an ongoing, patient-empowered management plan.
Each BreatheAmerica center also follows a model that is allergist led, while allowing nurse practitioners extensive interaction with patients. Our providers spend a significant amount of time with each patient and are highly focused on medical condition specific education, which can lead to much needed life style changes. We believe all of these innovations position BreatheAmerica well for the health system we see evolving in the U.S.
Allergic rhinitis affects between 10% and 30% of all adults and as many as 40% of children.
Immunotherapy helps reduce hay fever symptoms in about 85% of people with allergic rhinitis.
Approximately 12% of Americans under the age of 45 have symptoms of chronic sinusitis.
It is estimated that the number of people with asthma will grow by more than 100 million by 2025.